Download Medical Notes on EvaluatePharma Orphan Drug Report 2020

EvaluatePharma Orphan Drug Report 2020 Medical Notes

About This Presentation

Description:Ever wondered what will the orphan drug landscape look like in the year 2024? Big pharma's recent dominance of the orphan market has invited calls to amend the orphan drug act in the United States. Regardless, orphan drug sales are expected to increase from $119bn in 2018 to $217bn in 2024. Download and check this EvaluatePharma Orphan Drug Report 2020 to learn which company would lead with a 7.6% share of the total orphan market in 2024, which orphan drug would fetch $10bn in 2024, alone and what percentage of worldwide sales will pipeline orphan drugs make up in 2024.

Tags:Orphan drug, pharma, pharmaceutical, drug sales, EvaluatePharma

Published on: Jun 29, 2020 | Views : 2057 | Downloads : 1

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

Indian Biotechnology Industry Analysis by IBEF

Managed Care Models: The Benefit vs. Cost Balance

Drug Payment Methodologies

Indian Pharmaceuticals Industry Report by IBEF

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

Barbiturates and Benzodiazepine

2019 R&D Achievements New product launches, clinical trial activity, and investments

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage 2020 Preview – A Report on Pharmaceutical Industry

HEALTH A TO Z